INSTITUTION'S PROFILE
CHUM MS Center and Universite de Montreal, Montreal, Quebec, Canada.
Publications (1)
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
Journal: JAMA neurology
Publication date: 2023
Journal: JAMA neurology
Publication Year: 2023